Odense University Hospital, Osteoporosis Clinic
Odense, 5000, Denmark
NCT Number: NCT01199094
The aim of the study is to describe patients with a high bone mass phenotype due to a mutation in the low density lipoprotein l receptor 5 gene (LRP5) and compare them with age and sex matched controls. Moreover, bone density and microarchitecture as well as markers of bone metabolism are evaluated
Looking for future studies?
Notify Me8 year and older
All sexes
Observational
Odense, 5000, Denmark
Cases and controls are closely matched on age and sex and evaluated cross-sectionally.
Dual x-ray absorptiometry (DXA) and high resolution peripheral quantitative computed tomography (HR-pQCT) are used in order to evaluate bone density as well as microarchitecture. Bone turnover markers and body composition are also measured.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 weeks
HR-pQCT is used to evaluate bone microarchitecture, i.e. bone trabeculae, cortical thickness and trabecular number. Aim is to test if the microarchitecture of these patients are different that observed in normal controls
Time frame: 12 weeks
Markers of bone resorption and formation are investigated.
Time frame: 12 weeks
DXA is used to evaluate bone mineral density at total hip, spine, whole body and forearm.
Odense University Hospital
Other
Clinical Assessment of Patients With High Bone Mass Due to Mutation in Low Density Lipoprotein l Receptor 5
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01019876
Anemia, Anemia, Aplastic
New York, United States
View Trial DetailsNCT02666768
Bone Diseases, Bone Diseases, Developmental
Torrance, California, United States
View Trial DetailsNCT06521580
Bone Diseases, Bone Diseases, Developmental
Cairo, Manial, Egypt
View Trial DetailsNCT00730314
Agranulocytosis, Albinism
Los Angeles, California, United States
View Trial Details